Attention trainees and exam-takers.
The video recordings for this year’s @CLLSupport and @UkCllforum basic course are now available.
https://t.co/iaZ2XVcWdu
Register now to learn @cllsupport CLL basics and the latest updates over 3 Monday evenings. Great for exams and patient care.
Recordings will be made available after the events for those who have registered.
https://t.co/TcaRAbqGUU #pathology#cpd
Register now to learn @cllsupport CLL basics and the latest updates over 3 Monday evenings. Great for exams and patient care.
Recordings will be made available after the events for those who have registered.
https://t.co/TcaRAbqGUU
#pathology#cpd
Excited to share this international study now published @BloodPortfolio describing treatment-related survival in LBCL with secondary CNS involvement
Many thanks to @CwynKate@Diva_Baggio & all collaborators from 🇺🇸🇬🇧🇨🇦 that made this study possible
https://t.co/yr08k26KEQ
One week to go to our yearly CLL course in collaboration with @CLLSupport and with stellar speaker lineup. Still time to register:
https://t.co/LdrD0zNgj5
From basics to latest updates in the management of people with CLL.
#cll
Lots of exciting data on bispecific antibodies in lymphoma at #ASH25 this year - great to discuss our recent @BritSocHaem good practice paper with @wendster@SridharChaganti in this podcast - some practical tips for delivery and patient management
https://t.co/KELoDPx3NA
Produly announcing 2026 Complete CLL Course:
From basics to latest updates in the management of people with CLL
In collaboration with @CLLSupport, featuring :
Infection and CLL
What matters most to patients
Richter´s
Registration link-program 👇
https://t.co/sEV2NAlSmA
#CLL
@DrSStern@BritSocHaem@UKMyelomaSoc Congrats to you and all the authors! I will admit I just googled the gestation period of african elephants!!! This will be a really useful guidelines for HCPs in the UK and beyond! 👏🏽👏🏽
https://t.co/zrN1iFvae6
Updated British guidelines for Tumour lysis syndrome. @traceychan_1@drdavidoconnor
Impt update to improve safety of the anti cancer therapy we give.
Ensure from a safety aspect, rasburicase is available to patients who may develop TLS.
In an interview from #EHA2025, the lovely @DrDimaE (@royalmarsdenNHS) shares the results of the Waldenström’s macroglobulinemia cohort from a Phase I clinical trial investigating bexobrutideg, a BTK degrader, in B-cell malignancies:
👉 https://t.co/j6WEkkQz8e 👈
#LYMsm#CTSM
Great success of the @UkCllforum session at #BSH2025.
Many thanks to Prof Paul Moss, Prof Martin Dyer and Dima El-Sharkawi for their valuable, insightful and engaging talks.
See you in October in our Clinical Sciences meeting.
💙 Living with WM? Let’s Connect!
Join our Networking Session on 21 May in Chantilly, France, designed for those living with WM.
A stronger community starts with YOU. Register today:
https://t.co/GmBO7lowNu
#IWMF#2025EEF#Waldenstrom’s
It's not too late to book your tickets to the European WM Patient Forum. This event is a one of its kind, bringing together top experts so that you can get the latest updates and information, and even the chance to ask questions directly. Book here: https://t.co/gyeIZBcKOR
With exclusive sessions, the chance to ask world-leading experts questions, and the opportunity to have the first look at our new myWM app, the European WM Pateitn Forum is unmissable for anyone affected by WM. Book your tickets to reserve your spot today: https://t.co/gyeIZBcKOR
British Journal of Haematology | Wiley Online Library https://t.co/DnNKZ4MSLq I’m delighted to present and share the first ever study looking at checkpoint inhibition in WM. Thanks to all our collaborators especially @tobyeyre82 , @ShirleyDSa1 and all the trial patients
A jam-packed programme filled with clinicians, nurses, patients and experts from around Europe. WMUK and IWMF have been working hard to create a programme that meets the needs of patients and families, as told to us by patients and families. The agenda: https://t.co/6Z0HbOJ5nr
For those interested: consider applying for a new permanent myeloma consultant post @royalmarsdenNHS . Join a great team and an expanding myeloma service covering all aspects of myeloma care and clinical research, including T-cell based therapies! https://t.co/DfoeSFI1E3